Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Charmaine Gittleson purchased 1,666,666 shares of the stock in a transaction dated Tuesday, December 31st. The stock was purchased at an average cost of A$0.01 ($0.01) per share, for a total transaction of A$14,999.99 ($9,316.77).
Percheron Therapeutics Price Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Featured Stories
- Five stocks we like better than Percheron Therapeutics
- How to buy stock: A step-by-step guide for beginnersÂ
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- How to Plot Fibonacci Price Inflection Levels
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- These 3 Retail Stocks Can Keep Winning in 2025
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
